Skip to main content
Erschienen in: International Urology and Nephrology 5/2016

17.02.2016 | Nephrology - Editorial

Back to the future: restricted protein intake for conservative management of CKD, triple goals of renoprotection, uremia mitigation, and nutritional health

verfasst von: Csaba P. Kovesdy, Kamyar Kalantar-Zadeh

Erschienen in: International Urology and Nephrology | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Abstract

Lowering dietary protein intake (DPI) to approximately 0.6–0.8 g/kgBW/day may be renoprotective through various mechanisms, and it has been recommended in patients with non-dialysis-dependent chronic kidney disease (NDD-CKD) as a means to also control various metabolic consequences of advanced CKD, such as uremic symptoms, hyperparathyroidism, hypertension, hyperkalemia, and hyperphosphatemia. A meta-analysis in this issue of the Journal suggests that low-protein diet is effective and safe when used to retard progression of CKD and alleviate uremic complications. A potential deleterious consequence of lowering DPI in this population is the development or worsening of protein–energy wasting (PEW), which can contribute to poor clinical outcomes such as higher mortality and morbidity. There is currently insufficient high-level evidence to determine the ideal level of DPI in patients with NDD-CKD with high risk of PEW. For the time being we recommend a DPI of 0.6–0.8 g/kgBW/day, and increasing this as needed on an individual basis in patients with PEW. Further examination of this dilemma in randomized controlled clinical trials will be necessary.
Literatur
1.
Zurück zum Zitat Kalantar-Zadeh K, Tortorici AR, Chen JL et al (2015) Dietary restrictions in dialysis patients: Is there anything left to eat? Semin Dial 28:159–168CrossRefPubMedPubMedCentral Kalantar-Zadeh K, Tortorici AR, Chen JL et al (2015) Dietary restrictions in dialysis patients: Is there anything left to eat? Semin Dial 28:159–168CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Jiang Z, Zhang X, Yang L, Li Z, Qin W (2015) Effect of restricted protein diet supplemented with Keto analogues in chronic kidney disease: a systematic review and meta-analysis. Int Urol Nephrol Jiang Z, Zhang X, Yang L, Li Z, Qin W (2015) Effect of restricted protein diet supplemented with Keto analogues in chronic kidney disease: a systematic review and meta-analysis. Int Urol Nephrol
3.
Zurück zum Zitat Panel on Macronutrients ARot, Subcommittees on Upper Reference Levels of Nutrients and Interpretation and Uses of Dietary Reference Intakes, Standing Committee on the Scientific Evaluation of Dietary Reference Intakes (2005) Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids (Macronutrients). The National Academies Press, Washington Panel on Macronutrients ARot, Subcommittees on Upper Reference Levels of Nutrients and Interpretation and Uses of Dietary Reference Intakes, Standing Committee on the Scientific Evaluation of Dietary Reference Intakes (2005) Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids (Macronutrients). The National Academies Press, Washington
4.
Zurück zum Zitat National Kidney Foundation (2000) K/DOQI clinical practice guidelines for nutrition in chronic renal failure. Am J Kidney Dis 35:s1–s140 National Kidney Foundation (2000) K/DOQI clinical practice guidelines for nutrition in chronic renal failure. Am J Kidney Dis 35:s1–s140
5.
Zurück zum Zitat Fulgoni VL III (2008) Current protein intake in America: analysis of the National Health and Nutrition Examination Survey, 2003–2004. Am J Clin Nutr 87:1554S–1557SPubMed Fulgoni VL III (2008) Current protein intake in America: analysis of the National Health and Nutrition Examination Survey, 2003–2004. Am J Clin Nutr 87:1554S–1557SPubMed
6.
Zurück zum Zitat Deutz NE, Bauer JM, Barazzoni R et al (2014) Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN Expert Group. Clin Nutr 33:929–936CrossRefPubMedPubMedCentral Deutz NE, Bauer JM, Barazzoni R et al (2014) Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN Expert Group. Clin Nutr 33:929–936CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Ikizler TA, Cano NJ, Franch H et al (2013) Prevention and treatment of protein energy wasting in chronic kidney disease patients: a consensus statement by the International Society of Renal Nutrition and Metabolism. Kidney Int 84:1096–1107CrossRefPubMed Ikizler TA, Cano NJ, Franch H et al (2013) Prevention and treatment of protein energy wasting in chronic kidney disease patients: a consensus statement by the International Society of Renal Nutrition and Metabolism. Kidney Int 84:1096–1107CrossRefPubMed
8.
Zurück zum Zitat KDIGO (2012) clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3(1–150):2013 KDIGO (2012) clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3(1–150):2013
9.
Zurück zum Zitat Shah AP, Kalantar-Zadeh K, Kopple JD (2015) Is there a role for ketoacid supplements in the management of CKD? Am J Kidney Dis 65:659–673CrossRefPubMed Shah AP, Kalantar-Zadeh K, Kopple JD (2015) Is there a role for ketoacid supplements in the management of CKD? Am J Kidney Dis 65:659–673CrossRefPubMed
10.
Zurück zum Zitat Kovesdy CP, Kopple JD, Kalantar-Zadeh K (2013) Management of protein-energy wasting in non-dialysis-dependent chronic kidney disease: reconciling low protein intake with nutritional therapy. Am J Clin Nutr 97:1163–1177CrossRefPubMedPubMedCentral Kovesdy CP, Kopple JD, Kalantar-Zadeh K (2013) Management of protein-energy wasting in non-dialysis-dependent chronic kidney disease: reconciling low protein intake with nutritional therapy. Am J Clin Nutr 97:1163–1177CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Klahr S, Levey AS, Beck GJ et al (1994) The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease modification of diet in Renal Disease Study Group. N Engl J Med 330:877–884CrossRefPubMed Klahr S, Levey AS, Beck GJ et al (1994) The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease modification of diet in Renal Disease Study Group. N Engl J Med 330:877–884CrossRefPubMed
12.
Zurück zum Zitat Levey AS, Greene T, Beck GJ et al (1999) Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of diet in Renal Disease Study group. J Am Soc Nephrol 10:2426–2439PubMed Levey AS, Greene T, Beck GJ et al (1999) Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of diet in Renal Disease Study group. J Am Soc Nephrol 10:2426–2439PubMed
13.
Zurück zum Zitat D’Apolito M, Du X, Zong H et al (2010) Urea-induced ROS generation causes insulin resistance in mice with chronic renal failure. J Clin Invest 120:203–213CrossRefPubMedPubMedCentral D’Apolito M, Du X, Zong H et al (2010) Urea-induced ROS generation causes insulin resistance in mice with chronic renal failure. J Clin Invest 120:203–213CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Chauveau P, Combe C, Rigalleau V, Vendrely B, Aparicio M (2007) Restricted protein diet is associated with decrease in proteinuria: consequences on the progression of renal failure. J Ren Nutr 17:250–257CrossRefPubMed Chauveau P, Combe C, Rigalleau V, Vendrely B, Aparicio M (2007) Restricted protein diet is associated with decrease in proteinuria: consequences on the progression of renal failure. J Ren Nutr 17:250–257CrossRefPubMed
15.
Zurück zum Zitat Kasiske BL, Lakatua JD, Ma JZ, Louis TA (1998) A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function. Am J Kidney Dis 31:954–961CrossRefPubMed Kasiske BL, Lakatua JD, Ma JZ, Louis TA (1998) A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function. Am J Kidney Dis 31:954–961CrossRefPubMed
16.
Zurück zum Zitat Fouque D, Laville M (2009) Low protein diets for chronic kidney disease in non diabetic adults. Cochrane Database Syst Rev CD001892 Fouque D, Laville M (2009) Low protein diets for chronic kidney disease in non diabetic adults. Cochrane Database Syst Rev CD001892
17.
Zurück zum Zitat Robertson L, Waugh N, Robertson A (2007) Protein restriction for diabetic renal disease. Cochrane Database Syst Rev CD002181 Robertson L, Waugh N, Robertson A (2007) Protein restriction for diabetic renal disease. Cochrane Database Syst Rev CD002181
18.
19.
Zurück zum Zitat Ikizler TA, Greene JH, Wingard RL, Parker RA, Hakim RM (1995) Spontaneous dietary protein intake during progression of chronic renal failure. J Am Soc Nephrol 6:1386–1391PubMed Ikizler TA, Greene JH, Wingard RL, Parker RA, Hakim RM (1995) Spontaneous dietary protein intake during progression of chronic renal failure. J Am Soc Nephrol 6:1386–1391PubMed
20.
Zurück zum Zitat Kopple JD, Levey AS, Greene T et al (1997) Effect of dietary protein restriction on nutritional status in the modification of Diet in Renal Disease Study. Kidney Int 52:778–791CrossRefPubMed Kopple JD, Levey AS, Greene T et al (1997) Effect of dietary protein restriction on nutritional status in the modification of Diet in Renal Disease Study. Kidney Int 52:778–791CrossRefPubMed
21.
Zurück zum Zitat Menon V, Kopple JD, Wang X et al (2009) Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. Am J Kidney Dis 53:208–217CrossRefPubMed Menon V, Kopple JD, Wang X et al (2009) Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. Am J Kidney Dis 53:208–217CrossRefPubMed
22.
Zurück zum Zitat King AJ, Levey AS (1993) Dietary protein and renal function. J Am Soc Nephrol 3:1723–1737PubMed King AJ, Levey AS (1993) Dietary protein and renal function. J Am Soc Nephrol 3:1723–1737PubMed
23.
Zurück zum Zitat Wasserstein AG (1993) Changing patterns of medical practice: protein restriction for chronic renal failure. Ann Intern Med 119:79–85CrossRefPubMed Wasserstein AG (1993) Changing patterns of medical practice: protein restriction for chronic renal failure. Ann Intern Med 119:79–85CrossRefPubMed
24.
Zurück zum Zitat de Jong PE, Anderson S (1993) de ZD: glomerular preload and afterload reduction as a tool to lower urinary protein leakage: will such treatments also help to improve renal function outcome? J Am Soc Nephrol 3:1333–1341PubMed de Jong PE, Anderson S (1993) de ZD: glomerular preload and afterload reduction as a tool to lower urinary protein leakage: will such treatments also help to improve renal function outcome? J Am Soc Nephrol 3:1333–1341PubMed
25.
Zurück zum Zitat Kalantar-Zadeh K, Cano NJ, Budde K, Chazot C, Kovesdy CP, Mak RH, Mehrotra R, Raj DS, Sehgal AR, Stenvinkel P, Ikizler TA (2011) Diets and enteral supplements for improving outcomes in chronic kidney disease. Nat Rev Nephrol 7(7):369–384. doi:10.1038/nrneph.2011.60 CrossRefPubMed Kalantar-Zadeh K, Cano NJ, Budde K, Chazot C, Kovesdy CP, Mak RH, Mehrotra R, Raj DS, Sehgal AR, Stenvinkel P, Ikizler TA (2011) Diets and enteral supplements for improving outcomes in chronic kidney disease. Nat Rev Nephrol 7(7):369–384. doi:10.​1038/​nrneph.​2011.​60 CrossRefPubMed
26.
Zurück zum Zitat Lacson E Jr, Wang W, Zebrowski B, Wingard R, Hakim RM (2012) Outcomes associated with intradialytic oral nutritional supplements in patients undergoing maintenance hemodialysis: a quality improvement report. Am J Kidney Dis 60:591–600CrossRefPubMed Lacson E Jr, Wang W, Zebrowski B, Wingard R, Hakim RM (2012) Outcomes associated with intradialytic oral nutritional supplements in patients undergoing maintenance hemodialysis: a quality improvement report. Am J Kidney Dis 60:591–600CrossRefPubMed
27.
Zurück zum Zitat Chertow GM, Ling J, Lew NL, Lazarus JM, Lowrie EG (1994) The association of intradialytic parenteral nutrition administration with survival in hemodialysis patients. Am J Kidney Dis 24:912–920CrossRefPubMed Chertow GM, Ling J, Lew NL, Lazarus JM, Lowrie EG (1994) The association of intradialytic parenteral nutrition administration with survival in hemodialysis patients. Am J Kidney Dis 24:912–920CrossRefPubMed
28.
Zurück zum Zitat Cano NJ, Fouque D, Roth H et al (2007) Intradialytic parenteral nutrition does not improve survival in malnourished hemodialysis patients: a 2-year multicenter, prospective, randomized study. J Am Soc Nephrol 18:2583–2591CrossRefPubMed Cano NJ, Fouque D, Roth H et al (2007) Intradialytic parenteral nutrition does not improve survival in malnourished hemodialysis patients: a 2-year multicenter, prospective, randomized study. J Am Soc Nephrol 18:2583–2591CrossRefPubMed
29.
Zurück zum Zitat Graham KA, Reaich D, Channon SM et al (1996) Correction of acidosis in CAPD decreases whole body protein degradation. Kidney Int 49:1396–1400CrossRefPubMed Graham KA, Reaich D, Channon SM et al (1996) Correction of acidosis in CAPD decreases whole body protein degradation. Kidney Int 49:1396–1400CrossRefPubMed
30.
Zurück zum Zitat Graham KA, Reaich D, Channon SM, Downie S, Goodship TH (1997) Correction of acidosis in hemodialysis decreases whole-body protein degradation. J Am Soc Nephrol 8:632–637PubMed Graham KA, Reaich D, Channon SM, Downie S, Goodship TH (1997) Correction of acidosis in hemodialysis decreases whole-body protein degradation. J Am Soc Nephrol 8:632–637PubMed
31.
Zurück zum Zitat Lofberg E, Wernerman J, Anderstam B, Bergstrom J (1997) Correction of acidosis in dialysis patients increases branched-chain and total essential amino acid levels in muscle. Clin Nephrol 48:230–237PubMed Lofberg E, Wernerman J, Anderstam B, Bergstrom J (1997) Correction of acidosis in dialysis patients increases branched-chain and total essential amino acid levels in muscle. Clin Nephrol 48:230–237PubMed
32.
Zurück zum Zitat Verove C, Maisonneuve N, El AA, Boldron A, Azar R (2002) Effect of the correction of metabolic acidosis on nutritional status in elderly patients with chronic renal failure. J Ren Nutr 12:224–228CrossRefPubMed Verove C, Maisonneuve N, El AA, Boldron A, Azar R (2002) Effect of the correction of metabolic acidosis on nutritional status in elderly patients with chronic renal failure. J Ren Nutr 12:224–228CrossRefPubMed
33.
Zurück zum Zitat Movilli E, Zani R, Carli O et al (1998) Correction of metabolic acidosis increases serum albumin concentrations and decreases kinetically evaluated protein intake in haemodialysis patients: a prospective study. Nephrol Dial Transplant 13:1719–1722CrossRefPubMed Movilli E, Zani R, Carli O et al (1998) Correction of metabolic acidosis increases serum albumin concentrations and decreases kinetically evaluated protein intake in haemodialysis patients: a prospective study. Nephrol Dial Transplant 13:1719–1722CrossRefPubMed
34.
Zurück zum Zitat Niwa T, Nomura T, Sugiyama S et al (1997) The protein metabolite hypothesis, a model for the progression of renal failure: an oral adsorbent lowers indoxyl sulfate levels in undialyzed uremic patients. Kidney Int Suppl 62:S23–S28PubMed Niwa T, Nomura T, Sugiyama S et al (1997) The protein metabolite hypothesis, a model for the progression of renal failure: an oral adsorbent lowers indoxyl sulfate levels in undialyzed uremic patients. Kidney Int Suppl 62:S23–S28PubMed
35.
Zurück zum Zitat Schulman G, Agarwal R, Acharya M et al (2006) A multicenter, randomized, double-blind, placebo-controlled, dose-ranging study of AST-120 (Kremezin) in patients with moderate to severe CKD. Am J Kidney Dis 47:565–577CrossRefPubMed Schulman G, Agarwal R, Acharya M et al (2006) A multicenter, randomized, double-blind, placebo-controlled, dose-ranging study of AST-120 (Kremezin) in patients with moderate to severe CKD. Am J Kidney Dis 47:565–577CrossRefPubMed
36.
Zurück zum Zitat Montes-Delgado R, Guerrero Riscos MA, Garcia-Luna PP et al (1998) Treatment with low-protein diet and caloric supplements in patients with chronic kidney failure in predialysis. Comparative study. Rev Clin Esp 198:580–586PubMed Montes-Delgado R, Guerrero Riscos MA, Garcia-Luna PP et al (1998) Treatment with low-protein diet and caloric supplements in patients with chronic kidney failure in predialysis. Comparative study. Rev Clin Esp 198:580–586PubMed
Metadaten
Titel
Back to the future: restricted protein intake for conservative management of CKD, triple goals of renoprotection, uremia mitigation, and nutritional health
verfasst von
Csaba P. Kovesdy
Kamyar Kalantar-Zadeh
Publikationsdatum
17.02.2016
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 5/2016
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-016-1224-0

Weitere Artikel der Ausgabe 5/2016

International Urology and Nephrology 5/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Frühzeitige HbA1c-Kontrolle macht sich lebenslang bemerkbar

22.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes von Anfang an intensiv BZ-senkend zu behandeln, wirkt sich positiv auf Komplikationen und Mortalität aus – und das offenbar lebenslang, wie eine weitere Nachfolgeuntersuchung der UKPD-Studie nahelegt.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.